Avatrombopag OverviewAvatrombopag is a medication that has been developed for certain conditions that lead to thrombocytopenia (abnormally low platelet counts) such as thrombocytopenia associated with chronic liver disease in adult patients who are to undergo a planned medical or dental procedure. It was approved by the Food and Drug Administration in May 21, 2018. References ^ FDA approves new drug for patients with chronic liver disease who have low blood platelets and are undergoing ...
Read more Avatrombopag Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Avatrombopag
Recent Avatrombopag Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Tablet: 20mg
Other drugs which contain Avatrombopag or a similar ingredient: (1 result)
- DOPTELET Avatrombopag Maleate